Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin (Urorec) to facilitate renal stone removal
2013-003328-35Phase 3Terminated
- Sponsor
- CHD Vendée
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silodosin in nephrolithiasis, sponsored by CHD Vendée. Started Jun 2015; status: terminated.
02
Drugs
silodosin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on 2013-003328-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003328-35.